- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/33 - Fibroblasts
Patent holdings for IPC class A61K 35/33
Total number of patents in this class: 476
10-year publication summary
24
|
37
|
50
|
47
|
61
|
75
|
65
|
52
|
37
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Figene, LLC | 164 |
90 |
Spinalcyte, LLC | 48 |
25 |
Metcela Inc. | 13 |
9 |
MiMedx Group, Inc. | 209 |
8 |
Wisconsin Alumni Research Foundation | 3819 |
7 |
Allergan Sales, LLC | 257 |
7 |
The Johns Hopkins University | 5524 |
6 |
Scarcell Therapeutics | 14 |
6 |
Castle Creek Biosciences, LLC | 27 |
6 |
Centre National de La Recherche Scientifique | 10068 |
5 |
Elixirgen Therapeutics, Inc. | 41 |
5 |
The Regents of the University of California | 19493 |
4 |
FUJIFILM Corporation | 28506 |
4 |
Duke University | 3008 |
4 |
Cedars-Sinai Medical Center | 1132 |
4 |
Children's Medical Center Corporation | 1822 |
4 |
Minovia Therapeutics Ltd. | 51 |
4 |
Osiris Therapeutics, Inc. | 99 |
4 |
Flagship Pioneering Innovations V, Inc. | 222 |
4 |
Fractyl Health, Inc. | 79 |
4 |
Other owners | 266 |